"Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05924711 |
Recruitment Status :
Recruiting
First Posted : June 29, 2023
Last Update Posted : June 29, 2023
|
Tracking Information | |||||||
---|---|---|---|---|---|---|---|
First Submitted Date | June 6, 2023 | ||||||
First Posted Date | June 29, 2023 | ||||||
Last Update Posted Date | June 29, 2023 | ||||||
Actual Study Start Date | June 6, 2023 | ||||||
Estimated Primary Completion Date | July 5, 2023 (Final data collection date for primary outcome measure) | ||||||
Current Primary Outcome Measures |
Sinus membrane thickening changes after peri-implantitis treatment [ Time Frame: 6 months ] Sagital and coronal linear measurements of membrane thickening
|
||||||
Original Primary Outcome Measures | Same as current | ||||||
Change History | No Changes Posted | ||||||
Current Secondary Outcome Measures |
|
||||||
Original Secondary Outcome Measures | Same as current | ||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||
Descriptive Information | |||||||
Brief Title | "Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study". | ||||||
Official Title | "Association Between the Treatment of Peri-implantitis and the Resolution of Maxillary Sinusitis: a Case-control Study". | ||||||
Brief Summary | Scientific evidence regarding the influence of peri-implantitis on Schneider's membrane thickening is scarce and limited. Similarly, to date, there is no literature documenting the resolution of implant-associated maxillary sinusitis with peri-implantitis after treatment of peri-implantitis or removal of the implant. Therefore, the aim of this case-control study is to investigate the association between peri-implantitis and maxillary sinusitis. On the other hand, the changes that occur at the level of the maxillary sinus membrane after treatment of peri-implantitis or after implant explantation will be evaluated. | ||||||
Detailed Description | Background Scientific evidence regarding the influence of peri-implantitis on Schneider's membrane thickening is scarce and limited. Similarly, to date, there is no literature documenting the resolution of implant-associated maxillary sinusitis with peri-implantitis after treatment of peri-implantitis or removal of the implant. Objectives Therefore, the aim of this case-control study is to investigate the association between peri-implantitis and maxillary sinusitis. On the other hand, the changes that occur at the level of the maxillary sinus membrane after treatment of peri-implantitis or after implant explantation will be evaluated. Hypothesis H01: The presence of implants placed in the posterior maxillary region affected by peri-implantits is associated with sinus membrane thickening or maxillary sinusitis. H11: The presence of implants placed in the posterior maxillary region affected by peri-implantits is not associated with sinus membrane thickening or maxillary sinusitis. H02: Treatment of peri-implantitis in implants placed in the posterior maxillary region can resolve maxillary sinusitis or reduce sinus membrane thickening. H12: Treatment of peri-implantitis on implants placed in the posterior maxillary region cannot resolve maxillary sinusitis or reduce sinus membrane thickening. Material and methods Study design The study will present a case-control design. Patients will be retrospectively recruited from a private clinic exclusively dedicated to periodontics and implantology (Clínica CICOM, Badajoz, Spain). Study setting The study will be conducted in a private practice associated with the Universitat Internacional de Catalunya (UIC). The study protocol and informed consent will be reviewed by the Ethics Committee of the Universitat Internacional de Catalunya (UIC, Barcelona, Spain) and the Declaration of Helsinki, 1975, revised in 2013, will be followed. Study population All patients included in the study will sign the corresponding informed consent forms for each of the treatments received, as well as for the use of their demographic and radiographic data for scientific purposes. The subjects recruited will be edentulous (partial/total) patients who previously had implants placed in the posterior region of the maxilla for oral rehabilitation. The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis while in the control group the 20 subjects included will have implants with peri-implant health. Demographic data A set of demographic data shall be obtained and recorded:
|
||||||
Study Type | Observational | ||||||
Study Design | Observational Model: Case-Control Time Perspective: Retrospective |
||||||
Target Follow-Up Duration | Not Provided | ||||||
Biospecimen | Not Provided | ||||||
Sampling Method | Non-Probability Sample | ||||||
Study Population | All patients included in the study signed the corresponding informed consent forms for each of the treatments received, as well as for the use of their demographic and radiographic data for scientific purposes. The subjects recruited will be edentulous (partial/total) patients who previously had implants placed in the posterior region of the maxilla for oral rehabilitation. The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis while in the control group the 20 subjects included will have implants with peri-implant health. |
||||||
Condition |
|
||||||
Intervention | Other: Retrospective analysis of demographic and radiographic data previously obtained from the patient.
The patient's demographic data obtained previously by anamnesis and clinical examination will be retrospectively analyzsed. On the other hand, a radiographic evaluation including analysis of the implants, adjacent teeth and maxillary sinuses/sinus membranes shall be performed using computer software.
|
||||||
Study Groups/Cohorts |
|
||||||
Publications * | Not Provided | ||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
Recruitment Information | |||||||
Recruitment Status | Recruiting | ||||||
Estimated Enrollment |
40 | ||||||
Original Estimated Enrollment | Same as current | ||||||
Estimated Study Completion Date | July 15, 2023 | ||||||
Estimated Primary Completion Date | July 5, 2023 (Final data collection date for primary outcome measure) | ||||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||||||
Sex/Gender |
|
||||||
Ages | 18 Years to 80 Years (Adult, Older Adult) | ||||||
Accepts Healthy Volunteers | Not Provided | ||||||
Contacts |
|
||||||
Listed Location Countries | Spain | ||||||
Removed Location Countries | |||||||
Administrative Information | |||||||
NCT Number | NCT05924711 | ||||||
Other Study ID Numbers | PER-ECL-2023-02 | ||||||
Has Data Monitoring Committee | Yes | ||||||
U.S. FDA-regulated Product |
|
||||||
IPD Sharing Statement |
|
||||||
Current Responsible Party | Ramón Pons Calabuig, Universitat Internacional de Catalunya | ||||||
Original Responsible Party | Same as current | ||||||
Current Study Sponsor | Universitat Internacional de Catalunya | ||||||
Original Study Sponsor | Same as current | ||||||
Collaborators | Not Provided | ||||||
Investigators |
|
||||||
PRS Account | Universitat Internacional de Catalunya | ||||||
Verification Date | June 2023 |